Skip to content
ApprovedFDA approvedStrong evidence

Pitolisant

Prescription wakefulness medicine for adults with narcolepsy: eases daytime sleepiness and sudden attacks of muscle weakness.

NootropicPerformance BoosterEugeroicHistaminergicWakefulnessAcetylcholineDopamineAnti-fatigue

Pharmacology

ClassEugeroic · Histaminergic · Wakefulness
Primary targetHistamine H3 receptor, inverse agonist / antagonist
Targets3 receptor targets
Half-life10-12 h
OnsetDays to weeks (morning dosing)
EvidenceStrong evidence
Affected systemsAcetylcholineDopamineAnti-fatigue

Contents

DETAILED OVERVIEW

What is Pitolisant?

Pitolisant is a prescription medicine that increases wakefulness. It is approved in Europe and the United States for adults with narcolepsy, to reduce excessive daytime sleepiness and cataplexy (sudden attacks of muscle weakness); the brand name is Wakix. In the United States it is not a controlled substance, and it is not on the anti-doping list.

In the brain it boosts the release of histamine, a brain messenger that supports alertness and attention. Controlled trials back up its effect, but it is not a general brain booster; it is a medicine tied to a medical diagnosis. Insomnia, headache and nausea are common side effects. It can lengthen the heart's electrical cycle (the QT interval), so an ECG may be used to monitor it when needed. It cannot be used in severe liver damage, and it can make hormonal contraceptives less effective.

Mechanism

Histamine H3 inverse agonist

Half-life

10-12 hours

Onset

Morning dosing, titrated over ~3 weeks

Legal status

FDA/EMA Rx (Wakix), not scheduled in US

Safety note

Dose-dependent QT prolongation

Receptor profile

  • Histamine H3 autoreceptor (inverse agonist)Strong
  • Histamine release (downstream)Moderate
  • Cortical acetylcholine / dopamine (downstream)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Insomnia, sleep disturbance (with late dosing)
  • Headache (common)
  • Nausea, abdominal pain, decreased appetite
  • Anxiety, irritability
  • QT interval prolongation (dose-dependent, ECG consideration)
  • Increased heart rate

Contraindications · 6

  • Severe hepatic impairment (Child-Pugh C): contraindicated (FDA/EMA label)
  • Hormonal contraceptives: CYP3A4 induction reduces efficacy, backup contraception needed
  • Known QT prolongation, congenital long QT syndrome, or concomitant QT-prolonging drugs: caution / avoid
  • Breastfeeding: avoid (animal data suggest excretion in milk); pregnancy: limited data
  • Strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) raise exposure (halve the dose); strong CYP3A4 inducers (rifampicin) lower it
  • Severe renal impairment: dose adjustment required

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Pitolisant is an officially approved (FDA and EMA), prescription-only medication that promotes wakefulness by acting through a histamine-related brain mechanism. It's approved specifically for adult narcolepsy, where its purpose is to reduce excessive daytime sleepiness and cataplexy (sudden muscle-weakness attacks), taken once daily in the morning. Importantly, this is not an over-the-counter lifestyle "brain booster" but a medicine tied to a specific medical diagnosis.

Telegram

Have a question about Pitolisant?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC17H26ClNO
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.